Translating Research Into Practice: The Healthy Living after Cancer Partnership Project Guideline launch - timely initiation of systemic chemotherapy for the treatment of cancer  Pembrolizumab for Metastatic Melanoma – One Year Results of Named Patient Access Program Effect of age and lenvatinib treatment on overall survival for patients with ¹³¹I-refractory differentiated thyroid cancer in SELECT To hope or not to hope; that is the question.  Visualising Therapy: Evolving role of nuclear medicine in Management of Metastatic Neuroendocrine Tumours Merkel Cell Carcinoma of the skin- Research into a rare malignancy. Funding a regional cancer clinical trials centre through community engagement Integrating Cancer Self Management Strategies The experiences of mothers with multiple myeloma living in rural and regional Australia Unmet Needs of Asian and Caucasian Women with Breast Cancer: Findings from the Literature Are self-administered psychosocial interventions as efficacious as guided interventions in the management of chronic health conditions? Completeness of family history taken during initial consultation at the Flinders Cancer Clinic: an audit Generating the evidence - The Forgotten Cancers Project How accurately do research participants report a diagnosis of cancer? The development of an Indigenous cancer network - lessons learned Convenient Chemotherapy– A New Paradigm for Pharmacy Convenient Chemotherapy– A New Paradigm for Pharmacy Fertility Implications for Women with a BRCA1 or BRCA2 Germline Mutation CONTROL NETS: Capecitabine ON Temozolomide Radionuclide therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study Evaluating the utility of the QUAL-EC in the clinical care of patients with advanced cancer Nutritional status, weight loss and associated characteristics of patients with oesophageal and gastro-oesophageal (GOJ) cancer: a descriptive study Evaluation of response from axitinib as per Choi criteria in previously treated patients with metastatic renal cell carcinoma (mRCC) Symptom burden of Australia and New Zealand (ANZ) patients with Neuroendocrine Tumours (NET)  ‘Rethinking REAL-2: Real-life outcomes from an Australian retrospective audit of patients with metastatic oesophago-gastric adenocarcinoma (mOGC)’